Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas

References

• Nusslein-VolhardCWieschausEMutations affecting segment number and polarity in drosophilaNature198028757857958016776413
   PubMed Web of Science ®Google Scholar
• KraussSConcordetJPInghamPWA functionally conserved homolog of the drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryosCell1993757143114448269519
   PubMed Web of Science ®Google Scholar
• EchelardYEpsteinDJSt-JacquesBSonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarityCell1993757141714307916661
   PubMed Web of Science ®Google Scholar
• RiddleRDJohnsonRLLauferETabinCSonic hedgehog mediates the polarizing activity of the ZPACell1993757140114168269518
   PubMed Web of Science ®Google Scholar
• ChangDTLopezAvon KesslerDPProducts, genetic linkage and limb patterning activity of a murine hedgehog geneDevelopment199412011333933537720571
   PubMed Web of Science ®Google Scholar
• RoelinkHAugsburgerAHeemskerkJFloor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochordCell19947647617758124714
   PubMed Web of Science ®Google Scholar
• JiangJHuiCCHedgehog signaling in development and cancerDev Cell200815680181219081070
   PubMed Web of Science ®Google Scholar
• YangLXieGFanQXieJActivation of the hedgehog-signaling pathway in human cancer and the clinical implicationsOncogene201029446948119935712
   PubMed Web of Science ®Google Scholar
• VarjosaloMTaipaleJHedgehog: functions and mechanismsGenes Dev200822182454247218794343
   PubMed Web of Science ®Google Scholar
• CorbitKCAanstadPSinglaVNormanARStainierDYReiterJFVertebrate smoothened functions at the primary ciliumNature200543770611018102116136078
   PubMed Web of Science ®Google Scholar
• HuangfuDLiuARakemanASMurciaNSNiswanderLAndersonKVHedgehog signalling in the mouse requires intraflagellar transport proteinsNature20034266962838714603322
   PubMed Web of Science ®Google Scholar
• RohatgiRMilenkovicLScottMPPatched1 regulates hedgehog signaling at the primary ciliumScience2007317583637237617641202
   PubMed Web of Science ®Google Scholar
• AllenBLSongJYIzziLOverlapping roles and collective requirement for the coreceptors GAS1, CDO, and BOC in SHH pathway functionDev Cell201120677578721664576
   PubMedGoogle Scholar
• IzziLLevesqueMMorinSBoc and Gas1 each form distinct Shh receptor complexes with Ptch1 and are required for Shh-mediated cell proliferationDev Cell201120678880121664577
   PubMed Web of Science ®Google Scholar
• YaoSLumLBeachyPThe ihog cell-surface proteins bind hedgehog and mediate pathway activationCell2006125234335716630821
   PubMed Web of Science ®Google Scholar
• LinderBWeberSDittmannKAdamskiJHahnHUhmannAA Functional and putative physiological role of calcitriol in patched1/smoothened interactionThe J Biol Chem201529032196141962826126827
   PubMedGoogle Scholar
• ZhouZYaoXLiSDeubiquitination of Ci/Gli by Usp7/HAUSP regulates hedgehog signalingDev Cell2015341587226120032
   PubMedGoogle Scholar
• CohenMKichevaARibeiroAPtch1 and Gli regulate Shh signalling dynamics via multiple mechanismsNat Commun20156670925833741
   PubMedGoogle Scholar
• CanettieriGDi MarcotullioLConiSGrecoAGulinoATurning off the switch in medulloblastoma: the inhibitory acetylation of an oncogeneCell Cycle20109112047204820505339
   PubMed Web of Science ®Google Scholar
• ChiSXieGLiuHRab23 negatively regulates Gli1 transcriptional factor in a Su(Fu)-dependent mannerCell Signal20122461222122822365972
   PubMedGoogle Scholar
• JohnsonRLRothmanALXieJHuman homolog of patched, a candidate gene for the basal cell nevus syndromeScience19962725268166816718658145
   PubMed Web of Science ®Google Scholar
• HahnHWickingCZaphiropoulousPGMutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndromeCell19968568418518681379
   PubMed Web of Science ®Google Scholar
• WangDHClemonsNJMiyashitaTAberrant epithelial-mesenchymal hedgehog signaling characterizes barrett’s metaplasiaGastroenterology201013851810182220138038
   PubMed Web of Science ®Google Scholar
• GuDLiuHSuGHCombining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasisMol Cancer Ther20131261038104823468532
   PubMed Web of Science ®Google Scholar
• Faiao-FloresFAlves-FernandesDKPennacchiPCTargeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cellsOncogene2016 [Epub ahead of print]
   PubMedGoogle Scholar
• SchreckKCTaylorPMarchionniLThe Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistanceCli Cancer Res2010162460606070
   PubMedGoogle Scholar
• Domingo-DomenechJVidalSJRodriguez-BravoVSuppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehog-dependent tumor-initiating cellsCancer Cell201222337338822975379
   PubMed Web of Science ®Google Scholar
• KeysarSBLePNAndersonRTHedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerCancer Res201373113381339223576557
   PubMed Web of Science ®Google Scholar
• LiuZXuJHeJA critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistanceBlood2014124132061207125049282
   PubMedGoogle Scholar
• ZahreddineHACuljkovic-KraljacicBAssoulineSThe sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidationNature20145117507909324870236
   PubMed Web of Science ®Google Scholar
• Della CorteCMBellevicineCVicidominiGSMO Gene Amplification and activation of the hedgehog pathway as novel mechanisms of resistance to anti-epidermal growth factor receptor drugs in human lung cancerClin Cancer Res201521204686469726124204
   PubMed Web of Science ®Google Scholar
• AlonsoSHernandezDChangYTHedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistanceJ Clin Invest2016126124460446827775549
   PubMedGoogle Scholar
• LinEHKaoYRLinCAHedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinomaOncotarget2016717241792419327015549
   PubMedGoogle Scholar
• MudigondaTPearceDJYentzerBAWillifordPFeldmanSRThe economic impact of non-melanoma skin cancer: a reviewJ Natl Compr Canc Netw20108888889620870635
   PubMed Web of Science ®Google Scholar
• RubinLLde SauvageFJTargeting the hedgehog pathway in cancerNat Rev Drug Discov20065121026103317139287
   PubMed Web of Science ®Google Scholar
• LowJAde SauvageFJClinical experience with hedgehog pathway inhibitorsJ Clin Oncol201028365321532621041712
   PubMed Web of Science ®Google Scholar
• Basset-SeguinNSharpeHJde SauvageFJEfficacy of hedgehog pathway inhibitors in basal cell carcinomaMol Cancer Ther201514363364125585509
   PubMedGoogle Scholar
• PanSWuXJiangJDiscovery of NVP-LDE225, a potent and selective smoothened antagonistACS Med Chem Lett20101313013424900187
   PubMed Web of Science ®Google Scholar
• SharpeHJWangWHannoushRNde SauvageFJRegulation of the oncoprotein smoothened by small moleculesNat Chem Biol201511424625525785427
   PubMedGoogle Scholar
• WangCWuHEvronTStructural basis for smoothened receptor modulation and chemoresistance to anticancer drugsNat Commun20145435525008467
   PubMed Web of Science ®Google Scholar
• NachtergaeleSWhalenDMMydockLKStructure and function of the smoothened extracellular domain in vertebrate hedgehog signalingElife20132e0134024171105
   PubMedGoogle Scholar
• WangCWuHKatritchVStructure of the human smoothened receptor bound to an antitumour agentNature2013497744933834323636324
   PubMed Web of Science ®Google Scholar
• DanialCSarinKYOroAEChangALAn investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegibClin Cancer Res20162261325132926546616
   PubMed Web of Science ®Google Scholar
• ZollingerMLozac’hFHurhEEmotteCBaulyHSwartPAbsorption, distribution, metabolism, and excretion (ADME) of (1) (4) C-sonidegib (LDE225) in healthy volunteersCancer Chemother Pharmacol2014741637524817600
   PubMed Web of Science ®Google Scholar
• SharmaMRKarrisonTGKellBEvaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsClin Cancer Res201319113059306723553850
   PubMed Web of Science ®Google Scholar
• GrahamRALumBLCheetiSPharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein bindingClin Cancer Res20111782512252021300760
   PubMed Web of Science ®Google Scholar
• GoelVHurhESteinAPopulation pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumorsCancer Chemother Pharmacol201677474575526898300
   PubMed Web of Science ®Google Scholar
• ZhouJQuinlanMGlennKEffect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteersBr J Clin Pharmacol20168241022102927277189
   PubMed Web of Science ®Google Scholar
• MinamiHAndoYMaBBPhase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsCancer Sci2016107101477148327467121
   PubMedGoogle Scholar
• DummerRGuminskiAGutzmerRThe 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinomaJ Am Acad Dermatol2016751113125.e11527067394
   PubMed Web of Science ®Google Scholar
• MigdenMRGuminskiAGutzmerRTreatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trialLancet Oncol201516671672825981810
   PubMed Web of Science ®Google Scholar
• ZhouJQuinlanMHurhESellamiDExposure-response analysis of sonidegib (LDE225), an oral inhibitor of the hedgehog signaling pathway, for effectiveness and safety in patients with advanced solid tumorsJ Clin Pharmacol201656111406141527095306
   PubMedGoogle Scholar
• FanQGuDLiuHDefective TGF-beta signaling in bone marrow-derived cells prevents hedgehog-induced skin tumorsCancer Res201474247148324282281
   PubMedGoogle Scholar
• MaierTKulichovaDRuzickaTBerkingCNoninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regressionJ Am Acad Dermatol201471472573024928708
   PubMedGoogle Scholar
• PietanzaMCLitvakAMVargheseAMA phase I trial of the hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancerLung Cancer201699233027565909
   PubMed Web of Science ®Google Scholar
• LacoutureMEDrenoBAsciertoPACharacterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinomaOncologist201621101218122927511905
   PubMed Web of Science ®Google Scholar
• LauresserguesEHeuslerPLestienneFPharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse modelPharmacol Res Perspect201642e0021427069629
   PubMedGoogle Scholar
• SekulicAMigdenMROroAEEfficacy and safety of vismodegib in advanced basal-cell carcinomaN Eng J Med20123662321712179
   PubMed Web of Science ®Google Scholar
• LyonsTGO’KaneGMKellyCMEfficacy and safety of vismodegib: a new therapeutic agent in the treatment of basal cell carcinomaExpert Opin Drug Saf20141381125113225033383
   PubMed Web of Science ®Google Scholar
• SofenHGrossKGGoldbergLHA phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinomaJ Am Acad Dermatol201573199105.e10125913533
   PubMed Web of Science ®Google Scholar